Subscriptions Page
(Source: Clinical Infectious Diseases)
Source: Clinical Infectious Diseases - January 3, 2017 Category: Infectious Diseases Tags: Cover / Standing Material Source Type: research
Masthead
(Source: Clinical Infectious Diseases)
Source: Clinical Infectious Diseases - January 3, 2017 Category: Infectious Diseases Tags: Cover / Standing Material Source Type: research
Editorial Board
(Source: Clinical Infectious Diseases)
Source: Clinical Infectious Diseases - January 3, 2017 Category: Infectious Diseases Tags: Cover / Standing Material Source Type: research
Editorial Advisory Board
(Source: Clinical Infectious Diseases)
Source: Clinical Infectious Diseases - January 3, 2017 Category: Infectious Diseases Tags: Cover / Standing Material Source Type: research
Cover
(Source: Clinical Infectious Diseases)
Source: Clinical Infectious Diseases - January 3, 2017 Category: Infectious Diseases Tags: Cover / Standing Material Source Type: research
Zika Virus Genital Tract Shedding in Infected Women of Childbearing age
(Source: Clinical Infectious Diseases)
Source: Clinical Infectious Diseases - December 15, 2016 Category: Infectious Diseases Authors: Prisant, N., Breurec, S., Moriniere, C., Bujan, L., Joguet, G. Tags: CORRESPONDENCE Source Type: research
Antimicrobial Resistance: A Call to Action!
(Source: Clinical Infectious Diseases)
Source: Clinical Infectious Diseases - December 15, 2016 Category: Infectious Diseases Authors: Brown, L., Langelier, C., Reid, M. J. A., Rutishauser, R. L., Strnad, L. Tags: CORRESPONDENCE Source Type: research
Reply to Alffenaar et al
(Source: Clinical Infectious Diseases)
Source: Clinical Infectious Diseases - December 15, 2016 Category: Infectious Diseases Authors: Peloquin, C. A., Dorman, S. E., Vernon, A., Battista Migliori, G., Nahid, P. Tags: CORRESPONDENCE Source Type: research
Therapeutic Drug Monitoring in Tuberculosis: Practical Application for Physicians
(Source: Clinical Infectious Diseases)
Source: Clinical Infectious Diseases - December 15, 2016 Category: Infectious Diseases Authors: Alffenaar, J.-W. C., Tiberi, S., Verbeeck, R. K., Heysell, S. K., Grobusch, M. P. Tags: CORRESPONDENCE Source Type: research
The Point of Antimicrobial Susceptibility Testing Is to Inform Antimicrobial Prescribing
(Source: Clinical Infectious Diseases)
Source: Clinical Infectious Diseases - December 15, 2016 Category: Infectious Diseases Authors: Stover, K. R., Bland, C. M., Gallagher, J. C., for the Society of Infectious Diseases Pharmacists Tags: CORRESPONDENCE Source Type: research
Turkey Meat as Source of CC9/CC398 Methicillin-Resistant Staphylococcus aureus in Humans?
(Source: Clinical Infectious Diseases)
Source: Clinical Infectious Diseases - December 15, 2016 Category: Infectious Diseases Authors: Fetsch, A., Kraushaar, B., Käsbohrer, A., Hammerl, J. A. Tags: CORRESPONDENCE Source Type: research
Editorial Commentary: Decision Science at Work: The Case of Hepatitis C Virus Postexposure Prophylaxis
(Source: Clinical Infectious Diseases)
Source: Clinical Infectious Diseases - December 15, 2016 Category: Infectious Diseases Authors: Barocas, J. A., Linas, B. P. Tags: VIRAL HEPATITIS Source Type: research
Hepatitis C Virus Postexposure Prophylaxis in the Healthcare Worker: Why Direct-Acting Antivirals Don't Change a Thing
Currently, 380 000–400 000 occupational exposures to blood-borne pathogens occur annually in the United States. The management for occupational HIV or hepatitis B virus exposures includes postexposure prophylaxis (PEP) when necessary; however, PEP is not recommended for hepatitis C virus (HCV) exposures. Recent approval of HCV direct-acting antivirals (DAAs) has renewed discussions as to whether these therapies could be used to prevent infection after exposure. There are no published studies addressing this question, but the prescribing of DAAs for PEP has been reported. We will discuss the differences in transmissio...
Source: Clinical Infectious Diseases - December 15, 2016 Category: Infectious Diseases Authors: Naggie, S., Holland, D. P., Sulkowski, M. S., Thomas, D. L. Tags: VIRAL HEPATITIS Source Type: research
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials
Cytomegalovirus (CMV) infection and disease are important causes of morbidity and mortality in transplant recipients. For the purpose of developing consistent reporting of CMV outcomes in clinical trials, definitions of CMV infection and disease were developed and most recently published in 2002. Since then, there have been major developments in its diagnosis and management. Therefore, the CMV Drug Development Forum consisting of scientists, clinicians, regulators, and industry representatives has produced an updated version incorporating recent knowledge with the aim to support clinical research and drug development. The ...
Source: Clinical Infectious Diseases - December 15, 2016 Category: Infectious Diseases Authors: Ljungman, P., Boeckh, M., Hirsch, H. H., Josephson, F., Lundgren, J., Nichols, G., Pikis, A., Razonable, R. R., Miller, V., Griffiths, P. D., for the Disease Definitions Working Group of the Cytomegalovirus Drug Development Forum Tags: IMMUNOCOMPROMISED HOSTS Source Type: research
Cutaneous and Visceral Chronic Granulomatous Disease Triggered by a Rubella Virus Vaccine Strain in Children With Primary Immunodeficiencies
We describe 6 additional children with these findings, including 1 with visceral extension to the spleen. (Source: Clinical Infectious Diseases)
Source: Clinical Infectious Diseases - December 15, 2016 Category: Infectious Diseases Authors: Neven, B., Perot, P., Bruneau, J., Pasquet, M., Ramirez, M., Diana, J.-S., Luzi, S., Corre-Catelin, N., Chardot, C., Moshous, D., Leclerc Mercier, S., Mahlaoui, N., Aladjidi, N., Le Bail, B., Lecuit, M., Bodemer, C., Molina, T. J., Blanche, S., Eloit, M. Tags: BRIEF REPORTS Source Type: research
